Evidence map›Paper›PMID 40530216›Full record

ArticleCureus2025

Primary Ovarian Malignant Melanoma: A Case Report.

Maria Zoi Bourou, Theodoros Panoskaltsis, Despoina Myoteri, Porfyrios Korompelis, Panagiotis Vakas

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Maria Zoi BourouSecond Department of Obstetrics and Gynecology, National and Kapodistrian University of Athens Medical School, Aretaieio University Hospital, Athens, GRC.
Theodoros PanoskaltsisSecond Department of Obstetrics and Gynecology, National and Kapodistrian University of Athens Medical School, Aretaieio University Hospital, Athens, GRC.
Despoina MyoteriDepartment of Pathology, National and Kapodistrian University of Athens Medical School, Aretaieio University Hospital, Athens, GRC.
Porfyrios KorompelisDepartment of Gynecologic Oncology, Queen Elizabeth Hospital, Gateshead, GBR.
Panagiotis VakasSecond Department of Obstetrics and Gynecology, National and Kapodistrian University of Athens Medical School, Aretaieio University Hospital, Athens, GRC.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary ovarian melanoma (POM) is an exceedingly rare and aggressive form of melanoma that arises in the ovaries, distinct from metastatic ovarian melanoma, which is far more common. The rarity of this condition, coupled with its clinical similarities to other types of ovarian malignancies, makes it a challenging entity to diagnose and manage. We present the case of a 56-year-old woman who underwent a laparoscopically assisted vaginal hysterectomy and bilateral salpingo-oophorectomy due to pelvic organ prolapse and a left adnexal mass. The final histology showed a POM. She received adjuvant immunotherapy, and a year after the initial diagnosis, the patient remains alive and well, without any signs of recurrence or distant disease.

Indexed as

adnexal masscase reportpelvic organ prolapseprimary ovarian malignant melanomarare tumors

Identifiers

PMID40530216
PMCPMC12170234

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.